Wolverine Trading, LLC Merrimack Pharmaceuticals Inc Call Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Call Options

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held	SEC Form
Q2 2022 Aug 15, 2022	SELL	$4.89 - $7.13 $71,394 - $104,098	-14,600 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$3.75 - $6.82 $1,875 - $3,410	500 Added 3.55%	14,600 $91,000
Q4 2020 Feb 12, 2021	BUY	$3.69 - $8.31 $52,029 - $117,171	14,100 New	14,100 $97,000
Q1 2020 May 11, 2020	SELL	$1.63 - $3.58 $19,071 - $41,886	-11,700 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$3.15 - $4.67 $36,855 - $54,639	11,700 New	11,700 $37,000
Q3 2019 Nov 14, 2019	SELL	$4.16 - $6.05 $42,432 - $61,710	-10,200 Closed	0 $0
Q2 2019 Aug 20, 2019	BUY	$4.39 - $5.66 $44,778 - $57,732	10,200 New	10,200 $62,000

Others Institutions Holding MACK

# of Institutions

2

Shares Held

349

Call Options Held

0

Put Options Held

0

About MERRIMACK PHARMACEUTICALS INC

Ticker MACK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,410,200
Market Cap $203M
Description
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

More about MACK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.